Non Animal Testing Database
EnglischDeutsch

Human ex vivo skin model with features of psoriatic lesions

Company
Genoskin, Toulouse, France
The skin model "InflammaSkin" developed by Genoskin represents a T-cell-driven skin inflammation model for psoriasis from epidermis, dermis and fatty tissue. The model has been shown to respond successfully to subcutaneous administration of the biological agent adalimumab.
Evaluation of pharmacological responses to subcutaneous injection of adalimumab in InflammaSkin®, a full-thickness human ex vivo skin model reproducing key features of psoriatic lesions
contact@genoskin.com
#346
Added on: 10-14-2020
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!